At Q-Gen Cell Therapeutics, we are advancing health through GMP cell manufacture. With more than 20 years of excellence in T-cell manufacturing supporting the immunotherapy industry, we continue to be a trusted partner locally and internationally.
Our key advantages and opportunities include:
Manufacture of autologous and allogeneic therapies
Complete on-site QC suite
Dedicated facilities
Competitive pricing
International collaborations and commercial partnerships
Responsive manufacturing
Competitive timelines
Capacity – 13 clean rooms
Efficient cell collection from Australia, Asia and USA
Seamless collection, manufacture and administration of cell-based products
On-site accredited quality control testing provides fast, reliable release testing of manufactured products
Experience with international regulators
TGA (Australian Regulator) licensed for:
Manufacture of T-Cell therapies for clinical trials
Quality control testing: potency; microbial contamination; endotoxin; mycoplasma; flow cytometry cell viability and identification
Regulatory documentation development
Q Gen Alloplex testimonial
Q-Gen Cell Therapeutics acknowledges the ongoing and valued support of: